| Name | Role stated in the filing | Named in |
|---|---|---|
| David Chernow | Executive Officer, Director | 2026-10-19, 2024-12-30 |
| Martin Jackson | Director | 2026-10-19, 2024-12-30 |
| Phillip Watts | Mr. Watts is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years., Promoter, Executive Officer, Director | 2026-10-19, 2024-12-30 |
| Robert Ortenzio | Director | 2026-10-19, 2024-12-30 |
| Steven Cutler | Mr. Cutler is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years., Promoter, Executive Officer | 2026-10-19, 2024-12-30 |
| Max Buetow | Director | 2026-10-19 |
| Stanley Marks, Md | Director | 2026-10-19 |
| Thomas Harper | Executive Officer, Promoter | 2024-12-30 |
| Thomas Harper, Jr. | Executive Officer, Promoter | 2026-10-19 |
| William Downey | Director | 2026-10-19 |
Want the whole picture on MODEL ONCOLOGY, LLC?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on MODEL ONCOLOGY, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on MODEL ONCOLOGY, LLC covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Names and roles exactly as the filings list them: executive officers, directors and promoters. Nothing here is inferred, and a filing only lists the people it is required to.